Clinical Trials
4 trialsNCT02710734 2026-05-22
Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)
Fox Chase Cancer Center
Phase 2 Completed
NCT06151847 2026-04-30
Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma
University of Kansas Medical Center
Phase 2 Completed
NCT02579980 2019-03-26
Quantitative Imaging Biomarkers for Sarcoma
Columbia University
Phase NA Completed
NCT00653250 2013-05-21
Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer
Vanderbilt-Ingram Cancer Center
Phase NA Completed